Michael Ronellenfitsch

2.5k total citations
73 papers, 1.3k citations indexed

About

Michael Ronellenfitsch is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Michael Ronellenfitsch has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Cancer Research and 26 papers in Genetics. Recurrent topics in Michael Ronellenfitsch's work include Glioma Diagnosis and Treatment (26 papers), Cancer, Hypoxia, and Metabolism (24 papers) and Brain Metastases and Treatment (13 papers). Michael Ronellenfitsch is often cited by papers focused on Glioma Diagnosis and Treatment (26 papers), Cancer, Hypoxia, and Metabolism (24 papers) and Brain Metastases and Treatment (13 papers). Michael Ronellenfitsch collaborates with scholars based in Germany, Luxembourg and United Kingdom. Michael Ronellenfitsch's co-authors include Joachim P. Steinbach, Patrick N. Harter, Christian Senft, Nadja I. Lorenz, Anna‐Luisa Luger, Johannes Rieger, Jörg Steinbach, Oliver Bähr, Volker Seifert and Donat Kögel and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Brain.

In The Last Decade

Michael Ronellenfitsch

66 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ronellenfitsch Germany 22 661 392 388 261 217 73 1.3k
Kar‐Ming Fung United States 18 915 1.4× 330 0.8× 262 0.7× 207 0.8× 128 0.6× 39 1.6k
Raelene Endersby Australia 16 671 1.0× 409 1.0× 244 0.6× 234 0.9× 109 0.5× 39 1.2k
Linda J. Metheny‐Barlow United States 21 755 1.1× 242 0.6× 434 1.1× 377 1.4× 410 1.9× 36 1.5k
Arata Tomiyama Japan 18 656 1.0× 238 0.6× 246 0.6× 238 0.9× 156 0.7× 73 1.2k
Zachary J. Reitman United States 16 763 1.2× 638 1.6× 663 1.7× 183 0.7× 177 0.8× 55 1.5k
Trang Nguyen United States 19 786 1.2× 159 0.4× 284 0.7× 162 0.6× 88 0.4× 42 1.2k
Michaela Gruber Austria 15 929 1.4× 160 0.4× 661 1.7× 138 0.5× 103 0.5× 30 1.6k
Andrew Kaufman United States 10 1.2k 1.8× 836 2.1× 770 2.0× 219 0.8× 257 1.2× 10 2.0k
Mingzhi Han China 21 795 1.2× 147 0.4× 429 1.1× 215 0.8× 258 1.2× 39 1.2k
Katja Kiseljak‐Vassiliades United States 20 398 0.6× 194 0.5× 354 0.9× 174 0.7× 127 0.6× 48 1.2k

Countries citing papers authored by Michael Ronellenfitsch

Since Specialization
Citations

This map shows the geographic impact of Michael Ronellenfitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ronellenfitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ronellenfitsch more than expected).

Fields of papers citing papers by Michael Ronellenfitsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ronellenfitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ronellenfitsch. The network helps show where Michael Ronellenfitsch may publish in the future.

Co-authorship network of co-authors of Michael Ronellenfitsch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ronellenfitsch. A scholar is included among the top collaborators of Michael Ronellenfitsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ronellenfitsch. Michael Ronellenfitsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorenz, Nadja I., Kevin Klann, Anna‐Luisa Luger, et al.. (2024). Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death. Cell Death Discovery. 10(1). 8–8. 3 indexed citations
2.
Straßheimer, F, Hans Urban, Stephanie Hehlgans, et al.. (2024). Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1. Cell Death Discovery. 10(1). 379–379. 7 indexed citations
3.
Kueckelhaus, Jan, Nadja I. Lorenz, Süleyman Bozkurt, et al.. (2024). An AMP‐activated protein kinase‐PGC‐1α axis mediates metabolic plasticity in glioblastoma. Clinical and Translational Medicine. 14(11). e70030–e70030. 3 indexed citations
4.
Harter, Patrick N., Katharina J. Weber, & Michael Ronellenfitsch. (2023). Histologische und molekularpathologische Besonderheiten von Tumoren des peripheren Nervensystems. PubMed. 44(3). 197–208.
5.
Schubert‐Bast, Susanne, Matthias Kieslich, Michael Ronellenfitsch, et al.. (2023). Trends and Differences in Status Epilepticus Treatment of Children and Adults Over 10 Years: A Comparative Study of Medical Records (2012–2021) from a University Hospital in Germany. CNS Drugs. 37(11). 993–1008. 4 indexed citations
6.
Baumgarten, Peter, Marcel A. Kamp, Vanessa Neef, et al.. (2023). Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat. Journal of Neuro-Oncology. 165(3). 509–515. 5 indexed citations
7.
Klann, Kevin, et al.. (2022). Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner. Cell Death Discovery. 8(1). 409–409. 8 indexed citations
8.
Stratmann, Jan, Martin Sebastian, Maximilian Rauch, et al.. (2022). Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients. Current Oncology. 29(4). 2225–2239. 1 indexed citations
9.
Urban, Hans, Eike Steidl, Elke Hattingen, et al.. (2022). Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization. Frontiers in Immunology. 12. 798811–798811. 13 indexed citations
10.
Voß, Martin, Katharina J. Wenger, Emmanouil Fokas, et al.. (2021). Single-shot bevacizumab for cerebral radiation injury. BMC Neurology. 21(1). 77–77. 13 indexed citations
11.
Raimann, Florian J., Vanessa Neef, Daniel Dubinski, et al.. (2021). Meningioma Surgery in Patients ≥70 Years of Age: Clinical Outcome and Validation of the SKALE Score. Journal of Clinical Medicine. 10(9). 1820–1820. 6 indexed citations
12.
Bernatz, Simon, Florian Geßler, Elke Hattingen, et al.. (2021). Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients. Journal of Molecular Histology. 52(2). 233–243. 10 indexed citations
13.
Lorenz, Nadja I., Kevin Klann, Christian Münch, et al.. (2020). Serine-dependent redox homeostasis regulates glioblastoma cell survival. British Journal of Cancer. 122(9). 1391–1398. 63 indexed citations
14.
Voß, Martin, Marlies Wagner, Patrick N. Harter, et al.. (2020). ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma. International Journal of Radiation Oncology*Biology*Physics. 108(4). 987–995. 67 indexed citations
15.
Voß, Martin, Eike Steidl, Marlies Wagner, et al.. (2019). Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab. Journal of Clinical Medicine. 8(10). 1608–1608. 2 indexed citations
16.
Ronellenfitsch, Michael, Pia S. Zeiner, Michel Mittelbronn, et al.. (2018). Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma. Acta Neuropathologica Communications. 6(1). 81–81. 22 indexed citations
17.
Ronellenfitsch, Michael, et al.. (2016). Activation of AMP-activated kinase modulates sensitivity of glioma cells against epidermal growth factor receptor inhibition. International Journal of Oncology. 49(1). 173–180. 7 indexed citations
18.
Steidl, Eike, Ulrich Pilatus, Elke Hattingen, et al.. (2016). Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. PLoS ONE. 11(12). e0168113–e0168113. 23 indexed citations
19.
20.
Ronellenfitsch, Michael, et al.. (1995). Kommunale Selbstverwaltung in Deutschland und Europa : Symposium zum 65. Geburtstag von Univ.-Prof. Dr. Willi Blümel. Duncker & Humblot eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kar‐Ming Fung Breakdown of academic impact, for papers by Raelene Endersby Breakdown of academic impact, for papers by Linda J. Metheny‐Barlow Breakdown of academic impact, for papers by Arata Tomiyama Breakdown of academic impact, for papers by Zachary J. Reitman Breakdown of academic impact, for papers by Trang Nguyen Breakdown of academic impact, for papers by Michaela Gruber Breakdown of academic impact, for papers by Andrew Kaufman Breakdown of academic impact, for papers by Mingzhi Han Breakdown of academic impact, for papers by Katja Kiseljak‐Vassiliades
Rankless by CCL
2026